Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
357 participants
OBSERVATIONAL
2013-06-30
2014-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
ADenoVirus Initiative Study in Epidemiology in UK
NCT02112773
ADenoVirus Initiative Study in Epidemiology in Germany
NCT02054273
ADenoVirus Initiative Study in Epidemiology in Spain
NCT02254330
ADenoVirus Initiative Study in Epidemiology in Italy
NCT03055065
Trial to Evaluate the Efficacy and Safety of IVIEW-1201 in Acute Viral Conjunctivitis
NCT03749317
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient or / and legal representative (if patient below 18 years of age) must be able to provide oral consent for the collection and treatment of the questionnaire data.
* No history of hypersensitivity to corn starch, talcum powder or Dacron (sampling fleece components).
Exclusion Criteria
* Previous enrolment in the present study.
* Any direct involvement with the study conduct at site or any family link with study site staff.
1 Year
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
NicOx
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Eric Tuil
Role: PRINCIPAL_INVESTIGATOR
CHNO Des Quinze-Vingts
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hôpital Avicenne
Bobigny, , France
Groupe hospitalier Pellegrin
Bordeaux, , France
CHU BREST- Hôpital Morvan
Brest, , France
Hôpital Kremlin-Bicêtre
Le Kremlin-Bicêtre, , France
CHRU de Lille
Lille, , France
Hospices Civils de Lyon
Lyon, , France
Hôpital de la Timone
Marseille, , France
Hopital Nord
Marseille, , France
GABISSON
Marseille, , France
CH Nantes
Nantes, , France
Centre hospitalier Saint Roch
Nice, , France
Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts
Paris, , France
Groupe Hospitalier La Pitié Salpêtrière-Charles Foix
Paris, , France
Fondation Rothschild
Paris, , France
Hôpital Tenon
Paris, , France
Hôpital Hôtel Dieu
Paris, , France
Hopital Pontchaillou
Rennes, , France
Nouvel Hôpital Civil
Strasbourg, , France
CHU Hôpital Bretonneau
Tours, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ADVISE France
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.